Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetic and PHarmacodynamic Analysis and Evaluation of Teriparatide (PTH 1-34) Between Sexes

NCT04921124 is registered in ClinicalTrials.gov with Norfolk and Norwich University Hospitals NHS Foundation Trust as lead sponsor.

NCT NCT04921124
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04921124 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetic and PHarmacodynamic Analysis and Evaluation of Teriparatide (PTH 1-34) Between Sexes
Lead sponsor
Norfolk and Norwich University Hospitals NHS Foundation Trust
Phase
Phase 3
Overall status
Completed
Start date
May 24, 2021
Completion date
July 9, 2021
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stress fracture